Hypomethylating Agent
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid Malignancies. (NCT05841771) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2023-01-01 |
Track Hypomethylating Agent automatically
Every clearance here is in the API, with alerts when new ones post.